This Keystone Symposium will be held at the Beaver Run Resort in Breckenridge, Colorado from January 16-20. Its focus is on new developments in T cell therapy and its use in the treatment of cancer. It will feature talks from leaders in the field, as well as presentations of chosen papers. Registration is $1020 USD, with a $200 discount before November 20, 2017. Student discounts are available.
Sponsored by Amgen Inc., Inc.te Corporation, Juno Therapeutics, Regeneron Pharmaceuticals, Inc., Surface Oncology and TESARO, Inc.
IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.